UPDATED: Congressional reps urge the NIH to ‘march in’ on rising drug prices

Emily Wasserman

Up in arms about , a cadre of lawmakers have called for action. But the lawmaking process won't happen quickly enough for some of them. They're urging officials at the National Institutes of Health (NIH) and the U.S. Department of Health and Human Services to take some "extraordinary" action.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS